Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form
Learn about Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form, its reported features, relevant specialists, and questions to d
Also known as: Autosomal recessive dystrophic epidermolysis bullosa generalisata mitis; Autosomal recessive dystrophic epidermolysis bullosa, non-Hallopeau-Siemens type; Generalized RDEB, intermediate form; RDEB, non-Hallopeau-Siemens type
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.
What it is
From: Orphanet
A rare dystrophic epidermolysis bullosa (DEB) characterized by generalized cutaneous and mucosal blistering that is not associated with severe deformities.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal blistering of the skin · Very frequent (99-80%)
- The presence of one or more bullae on the skin, defined as fluid-filled blisters more than 5 mm in diameter with thin walls.
- Abnormal circulating selenium concentration · Very frequent (99-80%)
- Any deviation from the normal circulating concentration of selenium.
- Anemia · Very frequent (99-80%)
- A reduction in erythrocytes volume or hemoglobin concentration.
- Atypical scarring of skin · Very frequent (99-80%)
- Atypically scarred skin .
- Decreased body weight · Very frequent (99-80%)
- Abnormally low body weight.
- Fragile skin · Very frequent (99-80%)
- Skin that splits easily with minimal injury.
- Growth delay · Very frequent (99-80%)
- A deficiency or slowing down of growth pre- and postnatally.
- Abnormal esophagus morphology · Frequent (79-30%)
- A structural abnormality of the esophagus.
- Carious teeth · Frequent (79-30%)
- Caries is a multifactorial bacterial infection affecting the structure of the tooth. This term has been used to describe the presence of more than expected dental caries.
- Chronic cutaneous wound · Frequent (79-30%)
- A cutaneous wound that has failed to proceed through the orderly and timely process to produce an atomic and functional integrity, or proceeded through the repair process without establishing a sustained anatomic and functional result.
- Constipation · Frequent (79-30%)
- Infrequent or difficult evacuation of feces.
- Decreased circulating carnitine concentration · Frequent (79-30%)
- The concentration of carnitine in the blood circulation is below the lower limit of normal.
- Decreased serum iron · Frequent (79-30%)
- The concentration of iron cation in the blood circulation is below the lower limit of normal.
- Decreased serum zinc · Frequent (79-30%)
- A reduced concentration of zinc in the blood.
Other findings in the same source
From: Orphanet
Additional reported features include Dysphagia (Frequent (79-30%)); Esophageal stenosis (Frequent (79-30%)); Esophageal stricture (Frequent (79-30%)); Failure to thrive (Frequent (79-30%)); Feeding difficulties (Frequent (79-30%)); Gastroesophageal reflux (Frequent (79-30%)); Hypoalbuminemia (Frequent (79-30%)); Low levels of vitamin D (Frequent (79-30%)); Malnutrition (Frequent (79-30%)); Milia (Frequent (79-30%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Neonatal
Inheritance in the source
From: Orphanet
Autosomal recessive
Understanding the inheritance label
From: MedlinePlus Genetics
An autosomal recessive pattern usually involves disease-causing changes in both copies of a gene. Parents may each carry one altered copy without having the condition themselves. A genetic counsellor can explain carrier testing and reproductive implications using the actual laboratory findings, rather than the condition name alone.
Which doctor should you see?
The suggested department for discussing Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form is Dermatology, with a dermatologist as the relevant type of clinician. Dermatologist; paediatric services for children as appropriate.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Which features of the skin, hair or nails distinguish the possibilities?
- Would photographs over time help document the changes?
- What should be expected from treatment, and how will irritation or other adverse effects be managed?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a dermatologist. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Autosomal recessive generalized dystrophic epidermolysis bullosa, intermediate form — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- MedlinePlus Genetics — inheritance patterns — Public-domain Genetics education
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-0299.